Omeros will sell Omidria to Rayner Surgical Group Limited in a transaction valued at more than $1 billion, according to a press release from Omeros.
The transaction is expected to be finalized on or before Dec. 31 and includes an upfront payment of $125 million to Omeros. Additionally, Rayner will pay Omeros $200 million in a commercial milestone payment, the release said.
“We look forward to continue growing U.S. sales of Omidria and the rest of our portfolio and to launching EMA-approved Omidria throughout Europe and other regions of the (Read more...)